Binge Eating Disorder Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com
Dallas, TX (PRWEB) June 17, 2015 -- The report “Binge Eating Disorder - Pipeline Review, H1 2015” provides comprehensive information on the therapeutic development for Binge Eating Disorder. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on Binge Eating Disorder with 21 market data tables and 12 figures, spread across 41 pages is available at http://www.rnrmarketresearch.com/binge-eating-disorder-pipeline-review-h1-2015-market-report.html .
Companies discussed in this Binge Eating Disorder - Pipeline Review, H1 2015 report include Heptares Therapeutics Ltd., Lightlake Therapeutics Inc., Omeros Corporation, Polleo Pharma Limited, Teva Pharmaceutical Industries Limited.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Drug Profiles mentioned in this report are armodafinil, naloxone hydrochloride, OMS-527, Small Molecule to Antagonize Orexin 1 for Addiction and Compulsive Disorders, Small Molecules for Binge Eating Disorder.
Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392695 . (This is a premium report priced at US$2000 for a single user License.)
List of Tables
Number of Products under Development for Binge Eating Disorder, H1 2015 7
Number of Products under Development for Binge Eating Disorder - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Comparative Analysis by Unknown Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Binge Eating Disorder - Pipeline by Heptares Therapeutics Ltd., H1 2015 15
Binge Eating Disorder - Pipeline by Lightlake Therapeutics Inc., H1 2015 16
Binge Eating Disorder - Pipeline by Omeros Corporation, H1 2015 17
Binge Eating Disorder - Pipeline by Polleo Pharma Limited, H1 2015 18
Binge Eating Disorder - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015 19
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Stage and Target, H1 2015 22
Number of Products by Stage and Mechanism of Action, H1 2015 24
Number of Products by Stage and Route of Administration, H1 2015 26
Number of Products by Stage and Molecule Type, H1 2015 27
Binge Eating Disorder Therapeutics - Recent Pipeline Updates, H1 2015 35
Binge Eating Disorder - Dormant Projects, H1 2015 38
Binge Eating Disorder - Discontinued Products, H1 2015 39
List of Figures
Number of Products under Development for Binge Eating Disorder, H1 2015 7
Number of Products under Development for Binge Eating Disorder - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 12
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Top 10 Targets, H1 2015 21
Number of Products by Stage and Top 10 Targets, H1 2015 22
Number of Products by Top 10 Mechanism of Actions, H1 2015 23
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 24
Number of Products by Top 10 Routes of Administration, H1 2015 25
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 26
Number of Products by Stage and Top 10 Molecule Types, H1 2015 27
Explore more reports on Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .
More reports on Therapeutics:
Gonorrhea - Pipeline Review, H1 2015
The report “Gonorrhea - Pipeline Review, H1 2015” provides an overview of the Gonorrhea's therapeutic pipeline. Companies discussed in this report includes Genocea Biosciences, Inc., Melinta Therapeutics, Inc, Merck & Co., Inc., PTC Therapeutics, Inc. Complete report available at http://www.rnrmarketresearch.com/gonorrhea-pipeline-review-h1-2015-market-report.html .
Dysmenorrhea - Pipeline Review, H1 2015
This report provides comprehensive information on the therapeutic development for Dysmenorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Companies discussed in this report includes Merck & Co., Inc., ObsEva SA, PDC Biotech GmbH, Thar Pharmaceuticals, Inc. Complete report available at http://www.rnrmarketresearch.com/dysmenorrhea-pipeline-review-h1-2015-market-report.html .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article